SPONSORED CONTENT
The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient. Courts
…SPONSORED CONTENT
It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is
…SPONSORED CONTENT
Stay ahead of the latest developments shaping the 340B landscape with Ted Slafsky, Publisher and CEO of 340B Report. In this special, hour-long insider briefing, Ted will share timely insights, important context, and practical takeaways on the policy shifts and
…SPONSORED CONTENT
As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement spending,
…SPONSORED CONTENT
The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing. While this may be true in certain circumstances, organizations providing or considering offering specialty medications can still successfully navigate these complexities with
…SPONSORED CONTENT
As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to operate their 340B programs. This may include conducting an annual independent audit, financially reconciling the previous fiscal year, getting
…SPONSORED CONTENT
Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse Webinar Series.
… SPONSORED CONTENT
At the 340B Coalition winter conference in February, two major topics were impossible
…SPONSORED CONTENT
W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, “Uncontrolled variation is the enemy of quality.” In the realm of 340B, including 340B contract pharmacies, that change is both continual and constant.
…SPONSORED CONTENT
The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of the
…*Sign up for news summaries and alerts from 340B Report
